Cargando…
Favipiravir Inhibits Zika Virus (ZIKV) Replication in HeLa Cells by Altering Viral Infectivity
This study aims to evaluate the antiviral potential of the nucleoside analogue favipiravir (FAV) against ZIKV, an arbovirus for which there are no approved antiviral therapies, in three human-derived cell lines. HeLa (cervical), SK-N-MC (neuronal), and HUH-7 (liver) cells were infected with ZIKV and...
Autores principales: | Franco, Evelyn J., Hanrahan, Kaley C., Brown, Ashley N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223361/ https://www.ncbi.nlm.nih.gov/pubmed/37317071 http://dx.doi.org/10.3390/microorganisms11051097 |
Ejemplares similares
-
Favipiravir Suppresses Zika Virus (ZIKV) through Activity as a Mutagen
por: Franco, Evelyn J., et al.
Publicado: (2023) -
Combination Regimens of Favipiravir Plus Interferon Alpha Inhibit Chikungunya Virus Replication in Clinically Relevant Human Cell Lines
por: Franco, Evelyn J., et al.
Publicado: (2021) -
Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice
por: Kamiyama, Naganori, et al.
Publicado: (2017) -
Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication
por: Aagaard, Kjersti M., et al.
Publicado: (2017) -
Attenuation of Zika Virus by Passage in Human HeLa Cells
por: Li, Li, et al.
Publicado: (2019)